{"id":"rivaroxaban-dabigatran-apixaban-or-edoxaban","safety":{"commonSideEffects":[{"rate":"2-4%","effect":"Bleeding (major and minor)"},{"rate":"1-3%","effect":"Gastrointestinal bleeding"},{"rate":"5-11%","effect":"Dyspepsia"},{"rate":"5-10%","effect":"Nausea"},{"rate":"1-3%","effect":"Anemia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Rivaroxaban, apixaban, and edoxaban are Factor Xa inhibitors that block the conversion of prothrombin to thrombin, while dabigatran is a direct thrombin inhibitor that prevents thrombin-mediated clot formation. All four drugs reduce the ability of blood to clot, thereby preventing thromboembolism in conditions such as atrial fibrillation and venous thromboembolism.","oneSentence":"These are direct oral anticoagulants (DOACs) that inhibit specific clotting factors to prevent blood clot formation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:05:34.120Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Atrial fibrillation for stroke prevention"},{"name":"Deep vein thrombosis (DVT) treatment and prevention"},{"name":"Pulmonary embolism (PE) treatment and prevention"},{"name":"Acute coronary syndrome (select agents)"}]},"trialDetails":[{"nctId":"NCT03568890","phase":"PHASE4","title":"Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec","startDate":"2018-09-01","conditions":"Left Atrial Appendage Closure, Thrombosis, Stroke","enrollment":510},{"nctId":"NCT07497893","phase":"NA","title":"FENOX Trial (Comparative Effectiveness of Fexuprazan Co-therapy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants)","status":"NOT_YET_RECRUITING","sponsor":"Ewha Womans University Mokdong Hospital","startDate":"2026-12-01","conditions":"Atrial Fibrillation (AF), Upper Gastrointestinal Bleeding (UGIB), Gastrointestinal Hemorrhage (Clinically Important, Upper)","enrollment":1000},{"nctId":"NCT06650501","phase":"PHASE4","title":"Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia","status":"RECRUITING","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2026-01-15","conditions":"Staphylococcus Aureus Endocarditis, Staphylococcus Aureus Septicemia, Staphylococcus Aureus Bacteremia","enrollment":300},{"nctId":"NCT04045665","phase":"PHASE3","title":"Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2019-12-13","conditions":"Atrial Fibrillation, Stroke, Bleeding","enrollment":3200},{"nctId":"NCT03968393","phase":"PHASE4","title":"Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress","status":"RECRUITING","sponsor":"Population Health Research Institute","startDate":"2019-06-14","conditions":"Stroke, Atrial Fibrillation","enrollment":2270},{"nctId":"NCT03463317","phase":"PHASE4","title":"Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2018-02-28","conditions":"Atrial Fibrillation","enrollment":912},{"nctId":"NCT04684212","phase":"NA","title":"Can the Lambre Device Occlude IRRegular And Large Appendages in Patients With Non-Valvular AF","status":"WITHDRAWN","sponsor":"Brian O'Neill MD","startDate":"2024-06-01","conditions":"Atrial Fibrillation, Left Atrial Appendage Thrombosis, CVA","enrollment":""},{"nctId":"NCT06101667","phase":"NA","title":"Efficacy and Safety of Endovascular Recanalization for Acute Basilar Artery Occlusion With Extended Time Window (ANGEL-BAO)","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2023-10-15","conditions":"Acute Ischemic Stroke, Basilar Artery Occlusion","enrollment":224},{"nctId":"NCT06983795","phase":"","title":"Pioneering Advancements in Cardiocerebrovascular Interactions in the Asia pacFIC - Patent Foramen Ovale Study","status":"NOT_YET_RECRUITING","sponsor":"National University Hospital, Singapore","startDate":"2025-07","conditions":"Ischemic Stroke, Patent Foramen Ovale","enrollment":1000},{"nctId":"NCT04700826","phase":"PHASE4","title":"Preventing Stroke, Premature Death and Cognitive Decline in a Broader Community of Patients With Atrial Fibrillation","status":"RECRUITING","sponsor":"University of Birmingham","startDate":"2021-06-01","conditions":"Atrial Fibrillation","enrollment":3000},{"nctId":"NCT06957366","phase":"NA","title":"Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure","status":"RECRUITING","sponsor":"McMaster University","startDate":"2025-04-01","conditions":"Atrial Fibrillation (AF), VTE","enrollment":920},{"nctId":"NCT06449469","phase":"NA","title":"The Nordic Aortic Valve Intervention Trial 4 (NOTION-4)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2021-05-01","conditions":"Aortic Valve Stenosis, Cardiovascular Diseases, Heart Diseases","enrollment":352},{"nctId":"NCT06322953","phase":"PHASE3","title":"Timing to Restart Direct Oral Anticoagulants After Traumatic Intracranial Haemorrhage","status":"RECRUITING","sponsor":"Walton Centre NHS Foundation Trust","startDate":"2025-03-10","conditions":"Traumatic Intracranial Haemorrhage","enrollment":1084},{"nctId":"NCT06571149","phase":"PHASE4","title":"Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2025-03-14","conditions":"Ischemic Stroke","enrollment":906},{"nctId":"NCT05378035","phase":"","title":"DOAC in Chinese Patients With Atrial Fibrillation","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2022-09-28","conditions":"Atrial Fibrillation, Stroke, Stroke, Acute","enrollment":427},{"nctId":"NCT03996772","phase":"PHASE3","title":"PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2019-06-03","conditions":"Atrial Fibrillation, Intracerebral Hemorrhage","enrollment":319},{"nctId":"NCT03062319","phase":"PHASE4","title":"Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis","status":"TERMINATED","sponsor":"National Hospital Organization Osaka National Hospital","startDate":"2017-04-06","conditions":"Ischemic Stroke, Atrial Fibrillation, Atherothrombosis","enrollment":321},{"nctId":"NCT01924065","phase":"PHASE3","title":"Risk of Stroke and Silent Cerebrovascular Thromboembolism After Cardioversion of Atrial Fibrillation","status":"COMPLETED","sponsor":"Suleyman Demirel University","startDate":"2013-08","conditions":"Atrial Fibrillation, Cardioversion, Cerebrovascular Stroke","enrollment":112},{"nctId":"NCT04979780","phase":"","title":"Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort","status":"COMPLETED","sponsor":"Bayer","startDate":"2021-07-20","conditions":"Treatment of Venous Thromboembolism in Cancer Patients, Prophylaxis of Recurrent Venous Thromboembolism in Cancer Patients","enrollment":3708},{"nctId":"NCT05472766","phase":"NA","title":"Anticoagulation Therapy Timing in Atrial Fibrillation After Acute and Chronic Subdural Hematoma","status":"TERMINATED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2022-11-24","conditions":"Subdural Hematoma, Atrial Fibrillation","enrollment":1},{"nctId":"NCT06401616","phase":"PHASE4","title":"Can Patients With Atrial Fibrillation Safely Discontinue Anticoagulant Therapy After Cardiac Surgery? (ATLAAC)","status":"RECRUITING","sponsor":"Odense University Hospital","startDate":"2024-05-21","conditions":"Atrial Fibrillation, Left Atrial Appendage Absent, Anticoagulant Adverse Reaction","enrollment":1220},{"nctId":"NCT05006287","phase":"PHASE2","title":"The Safety of Non-vitamin K Oral Anticoagulants Compared to Warfarin Early After Cardiac Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Paul's Hospital, Canada","startDate":"2022-10-12","conditions":"Atrial Fibrillation","enrollment":100},{"nctId":"NCT04042155","phase":"","title":"Real-life Clinical Outcomes of Direct Oral Anticoagulants (MACACOD)","status":"UNKNOWN","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2019-07-29","conditions":"Atrial Fibrillation, Recurrent Venous Thromboembolism","enrollment":1600},{"nctId":"NCT04262492","phase":"","title":"International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants","status":"RECRUITING","sponsor":"Stéphane Zuily","startDate":"2020-10-21","conditions":"Antiphospholipid Syndrome, Thrombosis, Anticoagulants Causing Adverse Effects in Therapeutic Use","enrollment":500},{"nctId":"NCT04662515","phase":"","title":"NOACs in Oral and Maxillofacial Surgery: Impact on Post-operative Complications","status":"COMPLETED","sponsor":"Malmö University","startDate":"2016-06-01","conditions":"Surgery, Oral, Hemorrhage, Postoperative Complications","enrollment":216},{"nctId":"NCT03642509","phase":"NA","title":"Left Atrial Appendage Occlusion Versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2019-01-01","conditions":"Atrial Fibrillation, Stroke","enrollment":750},{"nctId":"NCT06144866","phase":"","title":"Evaluataion of NOAC Levels in Acute Stroke","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2020-05-01","conditions":"Ischemic Stroke, Anticoagulant Adverse Reaction","enrollment":1000},{"nctId":"NCT02744092","phase":"NA","title":"Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer","status":"COMPLETED","sponsor":"Alliance Foundation Trials, LLC.","startDate":"2016-12-13","conditions":"Cancer, Venous Thromboembolism, Deep Vein Thrombosis (DVT)","enrollment":811},{"nctId":"NCT03148457","phase":"NA","title":"Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2017-11-06","conditions":"Ischaemic Stroke","enrollment":2013},{"nctId":"NCT04195113","phase":"","title":"Perioperative Anticoagulant Use for Surgery Evaluation Emergency Registry","status":"COMPLETED","sponsor":"McMaster University","startDate":"2019-08-07","conditions":"Atrial Fibrillation, Venous Thromboembolism, Arterial Vascular Disease","enrollment":242},{"nctId":"NCT04002011","phase":"PHASE2","title":"DOAC Versus VKA After Cardiac Surgery","status":"WITHDRAWN","sponsor":"Laval University","startDate":"2022-03-09","conditions":"Anticoagulant-induced Bleeding","enrollment":""},{"nctId":"NCT02353585","phase":"","title":"Novel Oral Anticoagulants in Stroke Patients","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2014-12","conditions":"Ischemic Stroke, Intracranial Hemorrhages","enrollment":1050},{"nctId":"NCT03292666","phase":"","title":"Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2010-01-01","conditions":"Venous Thromboembolism, Anticoagulants and Bleeding Disorders","enrollment":39603},{"nctId":"NCT04151680","phase":"","title":"Anticoagulation on Demand After Percutaneous Coronary Intervention in High Bleeding Risk Patients","status":"UNKNOWN","sponsor":"University of Roma La Sapienza","startDate":"2019-12-01","conditions":"Ischemic Heart Disease, Atrial Fibrillation","enrollment":100},{"nctId":"NCT01999179","phase":"NA","title":"Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2014-06","conditions":"Venous Thrombosis, Neoplasms","enrollment":27},{"nctId":"NCT03182829","phase":"","title":"In Vitro Diagnostic Test for DOAC in Urine","status":"COMPLETED","sponsor":"Doasense GmbH","startDate":"2018-08-22","conditions":"Anticoagulant Therapy","enrollment":880},{"nctId":"NCT03153150","phase":"PHASE3","title":"Start or STop Anticoagulants Randomised Trial (SoSTART)","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2018-03-28","conditions":"Intracranial Hemorrhages, Intracranial Hemorrhage, Hypertensive, Subarachnoid Hemorrhage","enrollment":203},{"nctId":"NCT05027061","phase":"","title":"A Study of Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2021-04-02","conditions":"Non-Valvular Atrial Fibrillation (NVAF)","enrollment":11776},{"nctId":"NCT02935855","phase":"PHASE4","title":"ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON)","status":"COMPLETED","sponsor":"University of Pavia","startDate":"2015-09","conditions":"Diabetes","enrollment":300},{"nctId":"NCT04518735","phase":"","title":"Evolution of COVID-19 in Anticoagulated or Antiaggregated Patients (CORONA Study)","status":"COMPLETED","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2020-04-01","conditions":"Covid19","enrollment":1707},{"nctId":"NCT03537521","phase":"","title":"Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists (RADOA). Focus on New Antidots","status":"WITHDRAWN","sponsor":"Cardioangiologisches Centrum Bethanien","startDate":"2020-04","conditions":"Severe Bleeding, Urgent Surgery","enrollment":""},{"nctId":"NCT01722786","phase":"","title":"Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists","status":"COMPLETED","sponsor":"Cardioangiologisches Centrum Bethanien","startDate":"2014-04","conditions":"Severe Bleeding, Urgent Surgery","enrollment":272},{"nctId":"NCT04291287","phase":"","title":"Triple or Dual Antithrombotic Therapy After PCI (TRIDUAL-PCI) Coronary Intervention in Patients With Non-valvular Atrial Fibrillation. Real-world Italian Multicenter Registry (TRIDUAL-PCI)","status":"UNKNOWN","sponsor":"Scientific Institute San Raffaele","startDate":"2020-01-25","conditions":"Atrial Fibrillation, Myocardial Infarction, Anticoagulant-induced Bleeding","enrollment":1500},{"nctId":"NCT02998905","phase":"PHASE2","title":"NOACs for Stroke Prevention in Patients With Atrial Fibrillation and Previous ICH","status":"COMPLETED","sponsor":"Population Health Research Institute","startDate":"2017-04-26","conditions":"Atrial Fibrillation, Intracerebral Hemorrhage","enrollment":30},{"nctId":"NCT04047654","phase":"","title":"Efficacy and Safety of Oral Anticoagulants Among Thai Octogenarians With Nonvalvular Atrial Fibrillation","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2019-04-22","conditions":"Stroke, Atrial Fibrillation","enrollment":327},{"nctId":"NCT03970421","phase":"","title":"Severity Factors and Needed Observation Time at ED of Patients Wih Head Injury","status":"UNKNOWN","sponsor":"Hospital El Escorial","startDate":"2019-06","conditions":"Head Injury Other, Length of Stay, Delayed Complications","enrollment":300},{"nctId":"NCT03182218","phase":"","title":"Periprocedural Direct Oral Anticoagulant Management","status":"COMPLETED","sponsor":"Fundación para la Investigación del Hospital Clínico de Valencia","startDate":"2015-02","conditions":"Periprocedural Complication","enrollment":1100},{"nctId":"NCT01962545","phase":"PHASE4","title":"Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) Study","status":"COMPLETED","sponsor":"Satoshi Shizuta","startDate":"2013-11-05","conditions":"Atrial Fibrillation, Coronary Artery Disease","enrollment":690},{"nctId":"NCT03108872","phase":"","title":"Left Atrial Appendage Occlusion Versus New Oral Anticoagulants for Stroke Prevention in Patients With Non-valvular Atrial Fibrillation","status":"UNKNOWN","sponsor":"Sejong General Hospital","startDate":"2017-05-23","conditions":"Atrial Fibrillation","enrollment":300},{"nctId":"NCT02356432","phase":"","title":"Cerebral Microbleeds During NOACs or Warfarin Therapy in NVAF Patients With Acute Ischemic Stroke (CMB-NOW)","status":"UNKNOWN","sponsor":"Tokai University","startDate":"2015-03","conditions":"Ischemic Stroke, Atrial Fibrillation Symptomatic","enrollment":86}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4563,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Rivaroxaban, dabigatran, apixaban, or edoxaban","genericName":"Rivaroxaban, dabigatran, apixaban, or edoxaban","companyName":"Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec","companyId":"centre-de-recherche-de-l-institut-universitaire-de-cardiologie-et-de-pneumologie","modality":"Small molecule","firstApprovalDate":"","aiSummary":"These are direct oral anticoagulants (DOACs) that inhibit specific clotting factors to prevent blood clot formation. Used for Atrial fibrillation for stroke prevention, Deep vein thrombosis (DVT) treatment and prevention, Pulmonary embolism (PE) treatment and prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}